Open access · CC-BY
via OpenAlex
Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients
Sho‐ichi Yamagishi, Takanori Matsui, Yuka Kurokawa, Kei Fukami
BioResearch open access · 2016 · ▲ 8 citations
Abstract
Circulating levels of growth differentiation factor 11 (GDF11) have been shown to decrease with age in several mammalian species, and supplementation of GDF11 by heterochronic parabiosis or systemic administration reverses age-related organ damage. However, there is some controversy about the pathophysiological role of GDF11 in aging-associated organ damage. Since aging process is accelerated in uremia, we compared serum levels of GDF11 in hemodialysis (HD) patients with those in age-matched healthy controls, and then determined the independent clinical correlates of GDF11 in HD subjects. Sixty-two maintenance HD patients (34 male and 28 female; mean age, 52.6 years; mean duration of HD, 7.7 months) were enrolled in the present study. Twenty-nine age-matched subjects were used as a control. GDF11 was measured by a commercially available enzyme-linked immunosorbent assay kit. Serum GDF11 levels in HD patients were significantly higher than those in controls (9.4 ± 5.1 pg/mL vs. 7.3 ± 5.9 pg/mL). A statistical significance was demonstrated between GDF11 and hemoglobin (inversely). Multiple stepwise regression analysis revealed that hemoglobin (p < 0.001) was a sole independent correlate of GDF11 levels in HD patients (R (2) = 0.168). Our present study suggests that kinetics and regulation of circulating GDF11 may differ between normal physiological aging process and accelerated pathological aging conditions, such as uremia. Given that GDF11 has been shown to inhibit erythroid maturation in mice, elevation of GDF11 levels may be involved in erythropoietin-resistant anemia in HD patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1089/biores.2016.0015
- Canonical
- link ↗
- Fetched
- 2026-06-23 MST
Cite this
APA
Yamagishi, S., Matsui, T., Kurokawa, Y., & Fukami, K. (2016). Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients. <em>BioResearch open access</em>. https://doi.org/10.1089/biores.2016.0015
Vancouver
Yamagishi S, Matsui T, Kurokawa Y, Fukami K. Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients. BioResearch open access. 2016. doi:10.1089/biores.2016.0015.
BibTeX
@article{shoichi2016SerumL,
title = {Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients},
author = {Sho‐ichi Yamagishi and Takanori Matsui and Yuka Kurokawa and Kei Fukami},
journal = {BioResearch open access},
year = {2016},
doi = {10.1089/biores.2016.0015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JCR Journal of Clinical Rheumatology 2016
Citation only
Accelerated Age-Related Arterial Stiffness in Systemic Lupus Erythematosus Patients
Journal of Translational Medicine 2019
Open access · CC-BY
Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case–controlled study
Molecules 2018
Open access · CC-BY
Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies
Biological Research 2018
Open access · CC-BY
Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis
Aging 2021
Preprint · CC-BY
Growth differentiation factor 11: a “rejuvenation factor” involved in regulation of age-related diseases?
2020
Open access · CC-BY